Literature DB >> 23548663

Allergen content and in vivo allergenic activity of house dust mite extracts.

Anne Casset, Rudolf Valenta, Susanne Vrtala.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548663      PMCID: PMC4636051          DOI: 10.1159/000347047

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


× No keyword cloud information.
  3 in total

1.  Quality control of house dust mite extracts for allergen immunotherapy.

Authors:  Philippe Moingeon; Thierry Batard; Emmanuel Nony; Maud Hrabina; Franco Frati
Journal:  Int Arch Allergy Immunol       Date:  2013-03-15       Impact factor: 2.749

2.  Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines.

Authors:  Thierry Batard; Alexandre Hrabina; Xue Zhi Bi; Henri Chabre; Pierrick Lemoine; Marie-Noëlle Couret; Dominique Faccenda; Bertrand Villet; Philippe Harzic; Françoise André; Sock Yong Goh; Claude André; Fook Tim Chew; Philippe Moingeon
Journal:  Int Arch Allergy Immunol       Date:  2006-06-01       Impact factor: 2.749

3.  Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts.

Authors:  Anne Casset; Adriano Mari; Ashok Purohit; Yvonne Resch; Margit Weghofer; Rosetta Ferrara; Wayne R Thomas; Claudia Alessandri; Kuan-Wei Chen; Frédéric de Blay; Rudolf Valenta; Susanne Vrtala
Journal:  Int Arch Allergy Immunol       Date:  2012-06-21       Impact factor: 2.749

  3 in total
  8 in total

Review 1.  Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.

Authors:  Angelika Tscheppe; Heimo Breiteneder
Journal:  Int Arch Allergy Immunol       Date:  2017-05-04       Impact factor: 2.749

Review 2.  Anaphylaxis to insect venom allergens: role of molecular diagnostics.

Authors:  Markus Ollert; Simon Blank
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 3.  Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.

Authors:  Rudolf Valenta; Raffaela Campana; Margit Focke-Tejkl; Verena Niederberger
Journal:  J Allergy Clin Immunol       Date:  2016-02       Impact factor: 10.793

4.  Cut-off value of D. pteronyssinus specific IgE in double negative patients Der p 1 and Der p 2 and its clinical repercussion.

Authors:  Antonio Letrán; Ignacio García; Marisa Espinazo-Romeu; Carmen Moreno-Aguilar; Francisco Moreno
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

5.  Epicutaneously applied Der p 2 induces a strong TH 2-biased antibody response in C57BL/6 mice, independent of functional TLR4.

Authors:  C Stremnitzer; K Manzano-Szalai; P Starkl; A Willensdorfer; S Schrom; J Singer; U Reichart; S Akira; E Jensen-Jarolim
Journal:  Allergy       Date:  2014-04-16       Impact factor: 13.146

Review 6.  Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy.

Authors:  Katharina Marth; Margarete Focke-Tejkl; Christian Lupinek; Rudolf Valenta; Verena Niederberger
Journal:  Curr Treat Options Allergy       Date:  2014-02-26

7.  Allergen extracts and recombinant proteins: comparison of efficiency of in vitro allergy diagnostics using multiplex assay on a biological microchip.

Authors:  Olga Smoldovskaya; Guzel Feyzkhanova; Alla Arefieva; Sergei Voloshin; Olga Ivashkina; Yuriy Reznikov; Alla Rubina
Journal:  Allergy Asthma Clin Immunol       Date:  2016-03-13       Impact factor: 3.406

Review 8.  Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?

Authors:  Rudolf Valenta; Alexander Karaulov; Verena Niederberger; Yury Zhernov; Olga Elisyutina; Raffaela Campana; Margarete Focke-Tejkl; Mirela Curin; Leyla Namazova-Baranova; Jiu-Yao Wang; Ruby Pawankar; Musa Khaitov
Journal:  J Allergy Clin Immunol Pract       Date:  2018-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.